A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4900-4902

  Banerjee, Ritu ^a   Gretes, Michael ^b   Harlem, Christopher ^c   Basuino, Li ^c   Chambers, Henry F ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; CEFOXITIN; CEFTOBIPROLE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 2A;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; GENE MUTATION; GENE SEQUENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUTATION; PENICILLIN-BINDING PROTEINS;

EID: 78049302098     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00594-10     Document Type: Article

References (29)

1. Banerjee, R., M. Gretes, L. Basuino, N. Strynadka, and H. F. Chambers. 2008. In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 52: 2089-2096.
2. Boucher, H. W., G. H. Talbot, J. S. Bradley, J. J. E. Edwards, D. Gilbert, L. B. Rice, M. Scheld, B. Spellberg, and J. Bartlett. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12.
3. Chambers, H. F., M. J. Sachdeva, and C. J. Hackbarth. 1994. Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus. Biochem. J. 301:139-144.
4. Chen, Y.-J., J. Sims-Mourtada, J. Izzo, and K. S. C. Chao. 2007. Targeting the hedgehog pathway to mitigate treatment resistance. Cell Cycle 15:1826-1830.
5. Davies, T. A., M. G. P. Page, W. Shang, T. Andrew, M. Kania, and K. Bush. 2007. Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51:2621-2624.
6. Davies, T. A., W. Shang, and K. Bush. 2006. Activities of ceftobiprole and other β-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP1a, PBP2b, and PBP2x. Antimicrob. Agents Chemother. 50:2530-2532.
7. Deresinski, S. 2009. Vancomycin heteroresistance and methicillin- resistant Staphylococcus aureus. J. Infect. Dis. 199:605-609.
8. Elkins, C. A., L. B. Mullis, D. W. Lacher, and C. M. Jung. 2010. Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy. Antimicrob. Agents Chemother. 54:1007-1015.
9. Finan, J. E., G. L. Archer, M. J. Pucci, and M. W. Climo. 2001. Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:3070-3075.
10. Henze, U. U., and B. Berger-Bachi. 1996. Penicillin-binding protein 4 over-production increases β-lactam resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:2121-2125.
11. Henze, U. U., and B. Berger-Bachi. 1995. Staphylococcus aureus penicillin-binding protein 4 and intrinsic β-lactam resistance. Antimicrob. Agents Chemother. 39:2415-2422.
12. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
13. Holland, L. M., S. T. O'Donnell, D. A. Ryjenkov, L. Gomelsky, S. R. Slater, P. D. Fey, M. Gomelsky, and J. P. O'Gara. 2008. A Staphylococcal GGDEF domain protein regulates biofilm formation independently of cyclic dimeric GMP. J. Bacteriol. 190:5178-5189.
14. Katayama, Y., H. Z. Zhang, D. Hong, and H. F. Chambers. 2003. Jumping the barrier to β-lactam resistance in Staphylococcus aureus. J. Bacteriol. 185:5465-5472.
15. Katayama, Y., H.-Z. Zhong, and H. F. Chambers. 2003. Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to β-lactam antibiotics. Microb. Drug Resist. 4:329-336.
16. Leski, T. A., and A. Tomasz. 2005. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2a. J. Bacteriol. 187:1815.
17. Memmi, G., S. R. Filipe, M. G. Pinho, Z. Fu, and A. Cheung. 2008. Staphylococcus aureus PBP4 is essential for β-lactam resistance in communityacquired methicillin-resistant strains. Antimicrob. Agents Chemother. 52: 3955-3966.
18. Moisan, H., M. Pruneau, and F. Malouin. 2010. Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J. Antimicrob. Chemother. doi:10.1093/jac/dkp503.
19. Murakami, S. 2008. Multidrug efflux transporter, AcrB - the pumping mechanism. Curr. Opin. Struct. Biol. 18:459-465.
20. Mwangi, M. M., S. W. Wu, Y. Zhou, K. Sieradzki, H. de Lencastre, P. Richardson, D. Bruce, E. Rubin, E. Myers, E. D. Siggia, and A. Tomasz. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Nat. Acad. Sci. U. S. A. 104: 9451-9456.
21. Navratna, V., S. Nadig, V. Sood, K. Prasad, G. Arakere, and B. Gopal. 2010. Molecular basis for the role of Staphylococcus aureus penicillin binding protein 4 in antimicrobial resistance. J. Bacteriol. 192:134-144.
22. Noel, G. J. 2007. Clinical profile of ceftobiprole, a novel β-lactam antibiotic. Clin. Microbiol. Infect. 13(S2):25-29.
23. Ryjenkov, D. A., M. Tarutina, O. V. Moskvin, and M. Gomelsky. 2005. Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J. Bacteriol. 187:1792-1798.
24. Shang, F., T. Xue, H. Sun, L. Xing, S. Zhang, Z. Yang, L. Zhang, and B. Sun. 2009. The Staphylococcus aureus GGDEF domain-containing protein, GdpS, influences protein A gene expression in a cyclic diguanylic acid-independent manner. Infect. Immun. 77:2849-2856.
25. Sieradzki, K., M. G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946.
26. Sieradzki, K., R. B. Roberts, S. W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
27. Sieradzki, K., and A. Tomasz. 2003. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J. Bacteriol. 185:7103-7110. (Pubitemid 37509825)
28. Tornroth-Horsefield, S., P. Gourdon, R. Horsefield, L. Brive, N. Yamamoto, H. Mori, A. Snijer, and R. Neutze. 2007. Crystal structure of AcrB in complex with a single transmembrane subunit reveals another twist. Structure 15: 1663-1673. (Pubitemid 350213410)
29. Tu Quoc, P. H. T., P. Genevaux, M. Pajunen, H. Savilahti, C. Georgopoulos, J. Schrenzel, and W. L. Kelley. 2007. Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect. Immun. 75:1079-1088.